New ACC/AHA cholesterol guidelines push earlier detection and more aggressive lipid lowering, recommending LDL-C below 70 mg/dL for intermediate-risk patients and below 55 mg/dL for higher-risk groups.
The update shifts risk assessment earlier in life, calling for cholesterol screening in younger adults, use of the PREVENT calculator from age 30, and childhood screening around age 9 for familial hypercholesterolemia.
A one-time Lp(a) test is now advised because elevated levels are tied to roughly 40% higher heart-disease risk at 125 nmol/L and about double the risk at 250 nmol/L.
The guidance broadens personalized treatment with risk enhancers, coronary calcium scans, and add-on therapies such as ezetimibe, bempedoic acid, and PCSK9 inhibitors when statins alone do not lower LDL enough.
The changes respond to persistent cardiovascular risk—about 1 in 4 U.S. adults has elevated LDL—and reflect a wider prevention strategy as heart disease remains the leading global killer.
New cholesterol guidelines slash risk scores, so why might 20 million more Americans need statins?
The new goal for 'bad' cholesterol is an all-time low. What are the risks of pushing it that low?
Should every 9-year-old now be screened for high cholesterol under the new national guidelines?
Transforming Cardiovascular Prevention: The 2026 ACC/AHA PREVENT Risk Tool, New LDL-C Targets, and Universal Lp(a) Screening
Overview
The PREVENT risk tool, developed by the American Heart Association, marks a major evolution in cardiovascular disease prevention by offering more accurate and comprehensive risk estimates for heart attacks and stroke. Unlike previous methods such as the Pooled Cohort Equation, PREVENT uses data from 6.6 million individuals and expands its use to people as young as 30. This broader, updated approach allows for better identification of at-risk individuals and supports more personalized prevention strategies, reflecting a significant step forward in clinical integration and equity in cardiovascular care.